{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:14:47Z","timestamp":1792782887245,"version":"4.5.0"},"reference-count":147,"publisher":"Springer Science and Business Media LLC","issue":"19","license":[{"start":{"date-parts":[[2017,5,9]],"date-time":"2017-05-09T00:00:00Z","timestamp":1494288000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca (MIUR)","award":["2010FHH32M"],"award-info":[{"award-number":["2010FHH32M"]}],"id":[{"id":"https:\/\/ror.org\/0166hxq48","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["IG-12111"],"award-info":[{"award-number":["IG-12111"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1007\/s00018-017-2536-7","type":"journal-article","created":{"date-parts":[[2017,5,9]],"date-time":"2017-05-09T02:39:22Z","timestamp":1494297562000},"page":"3491-3507","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":79,"title":["Platelets as crucial partners for tumor metastasis: from mechanistic aspects to pharmacological targeting"],"prefix":"10.1007","volume":"74","author":[{"given":"Annalisa","family":"Contursi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Sacco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalia","family":"Grande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melania","family":"Dovizio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Patrignani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,9]]},"reference":[{"key":"2536_CR1","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/bjc.2016.304","volume":"115","author":"CR Smittenaar","year":"2016","unstructured":"Smittenaar CR, Petersen KA, Stewart K, Moitt N (2016) Cancer incidence and mortality projections in the UK until 2035. Br J Cancer 115:1147\u20131155","journal-title":"Br J Cancer"},{"key":"2536_CR2","unstructured":"World Health Organization (2009) WHO Report on the Global Tobacco Epidemic. Geneva, ISBN: 978 92 4 156391 8"},{"issue":"10","key":"2536_CR3","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1161\/CIRCULATIONAHA.111.067264","volume":"126","author":"JP Despr\u00e9s","year":"2012","unstructured":"Despr\u00e9s JP (2012) Body fat distribution and risk of cardiovascular disease: an update. Circulation 126(10):1301\u20131313","journal-title":"Circulation"},{"issue":"9754","key":"2536_CR4","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/S0140-6736(10)61543-7","volume":"376","author":"PM Rothwell","year":"2010","unstructured":"Rothwell PM, Wilson M, Elwin CE, Norrving B, Algra A, Warlow CP, Meade TW (2010) Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet 376(9754):1741\u20131750","journal-title":"Lancet"},{"issue":"9","key":"2536_CR5","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.jacc.2016.05.083","volume":"68","author":"P Patrignani","year":"2016","unstructured":"Patrignani P, Patrono C (2016) Aspirin and cancer. J Am Coll Cardiol 68(9):967\u2013976","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"2536_CR6","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/bcpt.12156","volume":"114","author":"M Dovizio","year":"2014","unstructured":"Dovizio M, Alberti S, Guillem-Llobat P, Patrignani P (2014) Role of platelets in inflammation and cancer: novel therapeutic strategies. Basic Clin Pharmacol Toxicol 114(1):118\u2013127","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"5","key":"2536_CR7","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.ccell.2015.09.018","volume":"28","author":"MG Best","year":"2015","unstructured":"Best MG, Sol N, Kooi I, Tannous J, Westerman BA, Rustenburg F, Schellen P, Verschueren H, Post E, Koster J, Ylstra B, Ameziane N, Dorsman J, Smit EF, Verheul HM, Noske DP, Reijneveld JC, Nilsson RJ, Tannous BA, Wesseling P, Wurdinger T (2015) RNA-Seq of tumor-educated platelets enables blood-based pan-cancer, multiclass, and molecular pathway cancer diagnostics. Cancer Cell 28(5):666\u2013676","journal-title":"Cancer Cell"},{"issue":"13","key":"2536_CR8","doi-asserted-by":"crossref","first-page":"3680","DOI":"10.1182\/blood-2011-03-344408","volume":"118","author":"RJ Nilsson","year":"2011","unstructured":"Nilsson RJ, Balaj L, Hulleman E, van Rijn S, Pegtel DM, Walraven M, Widmark A, Gerritsen WR, Verheul HM, Vandertop WP, Noske DP, Skog J, W\u00fcrdinger T (2011) Blood platelets contain tumor-derived RNA biomarkers. Blood 118(13):3680\u20133683","journal-title":"Blood"},{"issue":"12","key":"2536_CR9","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1172\/JCI27196","volume":"115","author":"M Gawaz","year":"2005","unstructured":"Gawaz M, Langer H, May AE (2005) Platelets in inflammation and atherogenesis. J Clin Invest 115(12):3378\u20133384","journal-title":"J Clin Invest"},{"issue":"5","key":"2536_CR10","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1182\/blood-2014-08-531582","volume":"126","author":"AT Franco","year":"2015","unstructured":"Franco AT, Corken A, Ware J (2015) Platelets at the interface of thrombosis, inflammation, and cancer. Blood 126(5):582\u2013588","journal-title":"Blood"},{"issue":"3","key":"2536_CR11","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.bbamcr.2015.07.008","volume":"1863","author":"M Yan","year":"2016","unstructured":"Yan M, Jurasz P (2016) The role of platelets in the tumor microenvironment: from solid tumors to leukemia. Biochim Biophys Acta 1863(3):392\u2013400","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"2536_CR12","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.devcel.2010.05.012","volume":"18","author":"M Egeblad","year":"2010","unstructured":"Egeblad M, Nakasone ES, Werb Z (2010) Tumors as organs: complex tissues that interface with the entire organism. Dev Cell 18(6):884\u2013901","journal-title":"Dev Cell"},{"key":"2536_CR13","doi-asserted-by":"crossref","first-page":"836","DOI":"10.7326\/M16-0577","volume":"164","author":"K Bibbins-Domingo","year":"2016","unstructured":"Bibbins-Domingo K, U.S. Preventive Services Task Force (2016) Aspirin use for the primary prevention of cardiovascular disease and colorectal cancer: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med 164:836\u2013845","journal-title":"Ann Intern Med"},{"issue":"4","key":"2536_CR14","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nrc.2016.25","volume":"16","author":"PS Steeg","year":"2016","unstructured":"Steeg PS (2016) Targeting metastasis. Nat Rev Cancer 16(4):201\u2013218","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"2536_CR15","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nrc3004","volume":"11","author":"LJ Gay","year":"2011","unstructured":"Gay LJ, Felding-Habermann B (2011) Contribution of platelets to tumour metastasis. Nat Rev Cancer 11(2):123\u2013134","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"2536_CR16","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.3390\/ijms13021951","volume":"13","author":"SJ Diaz-Cano","year":"2012","unstructured":"Diaz-Cano SJ (2012) Tumor heterogeneity: mechanisms and bases for a reliable application of molecular marker design. Int J Mol Sci 13(2):1951\u20132011","journal-title":"Int J Mol Sci"},{"issue":"6","key":"2536_CR17","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1172\/JCI39104","volume":"119","author":"R Kalluri","year":"2009","unstructured":"Kalluri R, Weinberg RA (2009) The basics of epithelial\u2013mesenchymal transition. J Clin Invest 119(6):1420\u20131428","journal-title":"J Clin Invest"},{"issue":"2","key":"2536_CR18","first-page":"117","volume":"3","author":"LJ Talbot","year":"2012","unstructured":"Talbot LJ, Bhattacharya SD, Kuo PC (2012) Epithelial\u2013mesenchymal transition, the tumor microenvironment, and metastatic behavior of epithelial malignancies. Int J Biochem Mol Biol 3(2):117\u2013136","journal-title":"Int J Biochem Mol Biol"},{"issue":"3","key":"2536_CR19","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000088069","volume":"69","author":"J T\u00edm\u00e1r","year":"2005","unstructured":"T\u00edm\u00e1r J, T\u00f3v\u00e1ri J, R\u00e1s\u00f3 E, M\u00e9sz\u00e1ros L, Bereczky B, Lapis K (2005) Platelet-mimicry of cancer cells: epiphenomenon with clinical significance. Oncology 69(3):185\u2013201","journal-title":"Oncology"},{"issue":"2","key":"2536_CR20","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/jcmm.12496","volume":"19","author":"L Qiao","year":"2015","unstructured":"Qiao L, Liang N, Zhang J, Xie J, Liu F, Xu D, Yu X, Tian Y (2015) Advanced research on vasculogenic mimicry in cancer. J Cell Mol Med 19(2):315\u2013326","journal-title":"J Cell Mol Med"},{"issue":"12","key":"2536_CR21","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.1172\/JCI26891","volume":"115","author":"SR Patel","year":"2005","unstructured":"Patel SR, Hartwig JH, Italiano JE Jr (2005) The biogenesis of platelets from megakaryocyte proplatelets. J Clin Invest 115(12):3348\u20133354","journal-title":"J Clin Invest"},{"issue":"3","key":"2536_CR22","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1182\/blood.V91.3.830","volume":"91","author":"F Norol","year":"1998","unstructured":"Norol F, Vitrat N, Cramer E, Guichard J, Burstein SA, Vainchenker W, Debili N (1998) Effects of cytokines on platelet production from blood and marrow CD34+ cells. Blood 91(3):830\u2013843","journal-title":"Blood"},{"key":"2536_CR23","volume-title":"Platelets","author":"AD Michelson","year":"2013","unstructured":"Michelson AD (2013) Platelets. Elsevier, London"},{"issue":"10","key":"2536_CR24","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1111\/j.1538-7836.2011.04478.x","volume":"9","author":"T Lhermusier","year":"2011","unstructured":"Lhermusier T, Chap H, Payrastre B (2011) Platelet membrane phospholipid asymmetry: from the characterization of a scramblase activity to the identification of an essential protein mutated in Scott syndrome. J Thromb Haemost 9(10):1883\u20131891","journal-title":"J Thromb Haemost"},{"issue":"3","key":"2536_CR25","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s12265-012-9445-9","volume":"6","author":"G Cimmino","year":"2013","unstructured":"Cimmino G, Golino P (2013) Platelet biology and receptor pathways. J Cardiovasc Transl Res 6(3):299\u2013309","journal-title":"J Cardiovasc Transl Res"},{"issue":"1","key":"2536_CR26","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1182\/blood.V32.1.148.148","volume":"32","author":"JG White","year":"1968","unstructured":"White JG (1968) Tubular elements in platelet granules. Blood 32(1):148\u2013156","journal-title":"Blood"},{"key":"2536_CR27","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4615-3796-0","volume-title":"Blood cell biochemestry","author":"JR Harris","year":"1991","unstructured":"Harris JR (1991) Blood cell biochemestry. Springer Science\u00a0+\u00a0Business Media, New York"},{"issue":"32","key":"2536_CR28","doi-asserted-by":"crossref","first-page":"21327","DOI":"10.1016\/S0021-9258(18)54636-6","volume":"266","author":"M Fukuda","year":"1991","unstructured":"Fukuda M (1991) Lysosomal membrane glycoproteins. Structure, biosynthesis, and intracellular trafficking. J Biol Chem 266(32):21327\u201321330","journal-title":"J Biol Chem"},{"issue":"1","key":"2536_CR29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0049-3848(99)00015-8","volume":"95","author":"A McNicol","year":"1999","unstructured":"McNicol A, Israels SJ (1999) Platelet dense granules: structure, function and implications for haemostasis. Thromb Res 95(1):1\u201318","journal-title":"Thromb Res"},{"issue":"4","key":"2536_CR30","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3109\/09537104.2012.690113","volume":"24","author":"QE Fuentes","year":"2013","unstructured":"Fuentes QE, Fuentes QF, Andr\u00e9s V, Pello OM, Font de Mora J, Palomo GI (2013) Role of platelets as mediators that link inflammation and thrombosis in atherosclerosis. Platelets 24(4):255\u2013262","journal-title":"Platelets"},{"issue":"4","key":"2536_CR31","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.blre.2009.04.001","volume":"23","author":"P Blair","year":"2009","unstructured":"Blair P, Flaumenhaft R (2009) Platelet alpha-granules: basic biology and clinical correlates. Blood Rev 23(4):177\u2013189","journal-title":"Blood Rev"},{"issue":"14","key":"2536_CR32","doi-asserted-by":"crossref","first-page":"3907","DOI":"10.1182\/blood-2010-12-327007","volume":"117","author":"M Chatterjee","year":"2011","unstructured":"Chatterjee M, Huang Z, Zhang W, Jiang L, Hultenby K, Zhu L, Hu H, Nilsson GP, Li N (2011) Distinct platelet packaging, release, and surface expression of proangiogenic and antiangiogenic factors on different platelet stimuli. Blood 117(14):3907\u20133911","journal-title":"Blood"},{"issue":"2","key":"2536_CR33","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1083\/jcb.96.2.382","volume":"96","author":"RM Senior","year":"1983","unstructured":"Senior RM, Griffin GL, Huang JS, Walz DA, Deuel TF (1983) Chemotactic activity of platelet alpha granule proteins for fibroblasts. J Cell Biol 96(2):382\u2013385","journal-title":"J Cell Biol"},{"issue":"2","key":"2536_CR34","doi-asserted-by":"crossref","first-page":"329","DOI":"10.4103\/2045-8932.114760","volume":"3","author":"LA Hargett","year":"2013","unstructured":"Hargett LA, Bauer NN (2013) On the origin of microparticles: from \u201cplatelet dust\u201d to mediators of intercellular communication. Pulm Circ 3(2):329\u2013340","journal-title":"Pulm Circ"},{"issue":"12","key":"2536_CR35","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1111\/j.1600-0854.2011.01225.x","volume":"12","author":"A Bobrie","year":"2011","unstructured":"Bobrie A, Colombo M, Raposo G, Th\u00e9ry C (2011) Exosome secretion: molecular mechanisms and roles in immune responses. Traffic 12(12):1659\u20131668","journal-title":"Traffic"},{"issue":"9","key":"2536_CR36","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1161\/CIRCRESAHA.110.226456","volume":"107","author":"SF Mause","year":"2010","unstructured":"Mause SF, Weber C (2010) Microparticles: protagonists of a novel communication network for intercellular information exchange. Circ Res 107(9):1047\u20131057","journal-title":"Circ Res"},{"issue":"3","key":"2536_CR37","doi-asserted-by":"crossref","first-page":"s17","DOI":"10.1161\/ATVBAHA.107.160218","volume":"28","author":"GA Zimmerman","year":"2008","unstructured":"Zimmerman GA, Weyrich AS (2008) Signal-dependent protein synthesis by activated platelets: new pathways to altered phenotype and function. Arterioscler Thromb Vasc Biol 28(3):s17\u2013s24","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"10","key":"2536_CR38","doi-asserted-by":"crossref","first-page":"5556","DOI":"10.1073\/pnas.95.10.5556","volume":"95","author":"AS Weyrich","year":"1998","unstructured":"Weyrich AS, Dixon DA, Pabla R, Elstad MR, McIntyre TM, Prescott SM, Zimmerman GA (1998) Signal-dependent translation of a regulatory protein, Bcl-3, in activated human platelets. Proc Natl Acad Sci USA 95(10):5556\u20135561","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"2536_CR39","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1161\/01.RES.0000214553.37930.3e","volume":"98","author":"V Evangelista","year":"2006","unstructured":"Evangelista V, Manarini S, Di Santo A, Capone ML, Ricciotti E, Di Francesco L, Tacconelli S, Sacchetti A, D\u2019Angelo S, Scilimati A, Sciulli MG, Patrignani P (2006) De novo synthesis of cyclooxygenase-1 counteracts the suppression of platelet thromboxane biosynthesis by aspirin. Circ Res 98(5):593\u2013595","journal-title":"Circ Res"},{"issue":"6 Suppl","key":"2536_CR40","doi-asserted-by":"crossref","first-page":"199S","DOI":"10.1378\/chest.08-0672","volume":"133","author":"C Patrono","year":"2008","unstructured":"Patrono C, Baigent C, Hirsh J, Roth G (2008) Antiplatelet drugs: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133(6 Suppl):199S\u2013233S","journal-title":"Chest"},{"issue":"2","key":"2536_CR41","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1182\/blood-2008-03-145821","volume":"114","author":"H Yang","year":"2009","unstructured":"Yang H, Lang S, Zhai Z, Li L, Kahr WH, Chen P, Brki\u0107 J, Spring CM, Flick MJ, Degen JL, Freedman J, Ni H (2009) Fibrinogen is required for maintenance of platelet intracellular and cell-surface P-selectin expression. Blood 114(2):425\u2013436","journal-title":"Blood"},{"issue":"6","key":"2536_CR42","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1073\/pnas.061615598","volume":"98","author":"L Borsig","year":"2001","unstructured":"Borsig L, Wong R, Feramisco J, Nadeau DR, Varki NM, Varki A (2001) Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis. Proc Natl Acad Sci USA 98(6):3352\u20133357","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6611","key":"2536_CR43","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/385081a0","volume":"385","author":"F Austrup","year":"1997","unstructured":"Austrup F, Vestweber D, Borges E, L\u00f6hning M, Br\u00e4uer R, Herz U, Renz H, Hallmann R, Scheffold A, Radbruch A, Hamann A (1997) P- and E-selectin mediate recruitment of T-helper-1 but not T-helper-2 cells into inflammed tissues. Nature 385(6611):81\u201383","journal-title":"Nature"},{"issue":"5","key":"2536_CR44","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.immuni.2016.04.015","volume":"44","author":"R Tinoco","year":"2016","unstructured":"Tinoco R, Carrette F, Barraza ML, Otero DC, Maga\u00f1a J, Bosenberg MW, Swain SL, Bradley LM (2016) PSGL-1 is an immune checkpoint regulator that promotes T cell exhaustion. Immunity 44(5):1190\u20131203","journal-title":"Immunity"},{"issue":"12","key":"2536_CR45","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1172\/JCI26885","volume":"115","author":"IC Macaulay","year":"2005","unstructured":"Macaulay IC, Carr P, Gusnanto A, Ouwehand WH, Fitzgerald D, Watkins NA (2005) Platelet genomics and proteomics in human health and disease. J Clin Invest 115(12):3370\u20133377","journal-title":"J Clin Invest"},{"issue":"2","key":"2536_CR46","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1074\/mcp.M300063-MCP200","volume":"3","author":"JP McRedmond","year":"2004","unstructured":"McRedmond JP, Park SD, Reilly DF, Coppinger JA, Maguire PB, Shields DC, Fitzgerald DJ (2004) Integration of proteomics and genomics in platelets: a profile of platelet proteins and platelet-specific genes. Mol Cell Proteomics 3(2):133\u2013144","journal-title":"Mol Cell Proteomics"},{"issue":"4","key":"2536_CR47","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.bbalip.2014.09.016","volume":"1851","author":"P Patrignani","year":"2015","unstructured":"Patrignani P, Patrono C (2015) Cyclooxygenase inhibitors: from pharmacology to clinical read-outs. Biochim Biophys Acta 1851(4):422\u2013432","journal-title":"Biochim Biophys Acta"},{"issue":"Suppl 1","key":"2536_CR48","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1080\/13547500500215084","volume":"10","author":"P Patrignani","year":"2005","unstructured":"Patrignani P, Tacconelli S (2005) Isoprostanes and other markers of peroxidation in atherosclerosis. Biomarkers 10(Suppl 1):S24\u2013S29","journal-title":"Biomarkers"},{"key":"2536_CR49","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev.biochem.69.1.145","volume":"69","author":"WL Smith","year":"2000","unstructured":"Smith WL, DeWitt DL, Garavito RM (2000) Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem 69:145\u2013182","journal-title":"Annu Rev Biochem"},{"issue":"3","key":"2536_CR50","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0031-6997(25)06665-7","volume":"43","author":"SM Hourani","year":"1991","unstructured":"Hourani SM, Cusack NJ (1991) Pharmacological receptors on blood platelets. Pharmacol Rev 43(3):243\u2013298","journal-title":"Pharmacol Rev"},{"issue":"1","key":"2536_CR51","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0022-3565(25)38141-3","volume":"265","author":"GW Dorn 2nd","year":"1993","unstructured":"Dorn GW 2nd, Becker MW (1993) Thromboxane A2 stimulated signal transduction in vascular smooth muscle. J Pharmacol Exp Ther 265(1):447\u2013456","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"2536_CR52","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.clim.2006.01.016","volume":"119","author":"JY Park","year":"2006","unstructured":"Park JY, Pillinger MH, Abramson SB (2006) Prostaglandin E2 synthesis and secretion: the role of PGE2 synthases. Clin Immunol 119(3):229\u2013240","journal-title":"Clin Immunol"},{"issue":"3","key":"2536_CR53","first-page":"545P","volume":"40","author":"JB Smith","year":"1970","unstructured":"Smith JB, Willis AL (1970) Formation and release of prostaglandins by platelets in response to thrombin. Br J Pharmacol 40(3):545P\u2013546P","journal-title":"Br J Pharmacol"},{"issue":"4","key":"2536_CR54","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1172\/JCI59262","volume":"122","author":"WL Song","year":"2012","unstructured":"Song WL, Stubbe J, Ricciotti E, Alamuddin N, Ibrahim S, Crichton I, Prempeh M, Lawson JA, Wilensky RL, Rasmussen LM, Pur\u00e9 E, FitzGerald GA (2012) Niacin and biosynthesis of PGD2 by platelet COX-1 in mice and humans. J Clin Invest 122(4):1459\u20131468","journal-title":"J Clin Invest"},{"issue":"4","key":"2536_CR55","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1152\/physrev.1999.79.4.1193","volume":"79","author":"S Narumiya","year":"1999","unstructured":"Narumiya S, Sugimoto Y, Ushikubi F (1999) Prostanoid receptors: structures, properties, and functions. Physiol Rev 79(4):1193\u20131226","journal-title":"Physiol Rev"},{"issue":"5","key":"2536_CR56","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1172\/JCI10881","volume":"107","author":"JE Fabre","year":"2001","unstructured":"Fabre JE, Nguyen M, Athirakul K, Coggins K, McNeish JD, Austin S, Parise LK, FitzGerald GA, Coffman TM, Koller BH (2001) Activation of the murine EP3 receptor for PGE2 inhibits cAMP production and promotes platelet aggregation. J Clin Invest 107(5):603\u2013610","journal-title":"J Clin Invest"},{"issue":"1","key":"2536_CR57","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1172\/JCI27291","volume":"116","author":"T Grosser","year":"2006","unstructured":"Grosser T, Fries S, FitzGerald GA (2006) Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities. J Clin Invest 116(1):4\u201315","journal-title":"J Clin Invest"},{"issue":"5","key":"2536_CR58","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.tcm.2004.04.003","volume":"14","author":"L Zhao","year":"2004","unstructured":"Zhao L, Funk CD (2004) Lipoxygenase pathways in atherogenesis. Trends Cardiovasc Med 14(5):191\u2013195","journal-title":"Trends Cardiovasc Med"},{"issue":"5548","key":"2536_CR59","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1126\/science.294.5548.1871","volume":"294","author":"CD Funk","year":"2001","unstructured":"Funk CD (2001) Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 294(5548):1871\u20131875","journal-title":"Science"},{"issue":"3\u20134","key":"2536_CR60","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/BF00666105","volume":"13","author":"KV Honn","year":"1994","unstructured":"Honn KV, Tang DG, Gao X, Butovich IA, Liu B, Timar J, Hagmann W (1994) 12-lipoxygenases and 12(S)-HETE: role in cancer metastasis. Cancer Metastasis Rev 13(3\u20134):365\u2013396","journal-title":"Cancer Metastasis Rev"},{"issue":"9","key":"2536_CR61","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1073\/pnas.71.9.3400","volume":"71","author":"M Hamberg","year":"1974","unstructured":"Hamberg M, Samuelsson B (1974) Prostaglandin endoperoxides. Novel transformations of arachidonic acid in human platelets. Proc Natl Acad Sci USA 71(9):3400\u20133404","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"2536_CR62","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1042\/BJ20100415","volume":"431","author":"LT Morgan","year":"2010","unstructured":"Morgan LT, Thomas CP, K\u00fchn H, O\u2019Donnell VB (2010) Thrombin-activated human platelets acutely generate oxidized docosahexaenoic-acid-containing phospholipids via 12-lipoxygenase. Biochem J 431(1):141\u2013148","journal-title":"Biochem J"},{"issue":"12","key":"2536_CR63","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1194\/jlr.M026385","volume":"53","author":"KN Ikei","year":"2012","unstructured":"Ikei KN, Yeung J, Apopa PL, Ceja J, Vesci J, Holman TR, Holinstat M (2012) Investigations of human platelet-type 12-lipoxygenase: role of lipoxygenase products in platelet activation. J Lipid Res 53(12):2546\u20132559","journal-title":"J Lipid Res"},{"issue":"3","key":"2536_CR64","doi-asserted-by":"crossref","first-page":"154","DOI":"10.2174\/187152511797037619","volume":"9","author":"J Yeung","year":"2011","unstructured":"Yeung J, Holinstat M (2011) 12-lipoxygenase: a potential target for novel anti-platelet therapeutics. Cardiovasc Hematol Agents Med Chem 9(3):154\u2013164","journal-title":"Cardiovasc Hematol Agents Med Chem"},{"issue":"39","key":"2536_CR65","doi-asserted-by":"crossref","first-page":"33832","DOI":"10.1074\/jbc.M110.216564","volume":"286","author":"Y Guo","year":"2011","unstructured":"Guo Y, Zhang W, Giroux C, Cai Y, Ekambaram P, Dilly AK, Hsu A, Zhou S, Maddipati KR, Liu J, Joshi S, Tucker SC, Lee MJ, Honn KV (2011) Identification of the orphan G protein-coupled receptor GPR31 as a receptor for 12-(S)-hydroxyeicosatetraenoic acid. J Biol Chem 286(39):33832\u201333840","journal-title":"J Biol Chem"},{"issue":"5","key":"2536_CR66","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s11883-013-0323-y","volume":"15","author":"M Aldrovandi","year":"2013","unstructured":"Aldrovandi M, O\u2019Donnell VB (2013) Oxidized PLs and vascular inflammation. Curr Atheroscler Rep 15(5):323","journal-title":"Curr Atheroscler Rep"},{"issue":"11","key":"2536_CR67","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.bbalip.2011.07.018","volume":"1811","author":"VB O\u2019Donnell","year":"2011","unstructured":"O\u2019Donnell VB (2011) Mass spectrometry analysis of oxidized phosphatidylcholine and phosphatidylethanolamine. Biochim Biophys Acta 1811(11):818\u2013826","journal-title":"Biochim Biophys Acta"},{"issue":"10","key":"2536_CR68","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1182\/blood-2012-04-402826","volume":"120","author":"VB O\u2019Donnell","year":"2012","unstructured":"O\u2019Donnell VB, Murphy RC (2012) New families of bioactive oxidized phospholipids generated by immune cells: identification and signaling actions. Blood 120(10):1985\u20131992","journal-title":"Blood"},{"issue":"3","key":"2536_CR69","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nrc2809","volume":"10","author":"D Wang","year":"2010","unstructured":"Wang D, Dubois RN (2010) Eicosanoids and cancer. Nat Rev Cancer 10(3):181\u2013193","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"2536_CR70","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.yexcr.2011.12.017","volume":"318","author":"T Klampfl","year":"2012","unstructured":"Klampfl T, Bogner E, Bednar W, Mager L, Massudom D, Kalny I, Heinzle C, Berger W, St\u00e4ttner S, Karner J, Klimpfinger M, F\u00fcrstenberger G, Krieg P, Marian B (2012) Up-regulation of 12(S)-lipoxygenase induces a migratory phenotype in colorectal cancer cells. Exp Cell Res 318(6):768\u2013778","journal-title":"Exp Cell Res"},{"issue":"8","key":"2536_CR71","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1111\/j.1538-7836.2005.01379.x","volume":"3","author":"Y Ozaki","year":"2005","unstructured":"Ozaki Y, Asazuma N, Suzuki-Inoue K, Berndt MC (2005) Platelet GPIb-IX-V-dependent signaling. J Thromb Haemost 3(8):1745\u20131751","journal-title":"J Thromb Haemost"},{"issue":"7","key":"2536_CR72","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1161\/CIRCRESAHA.114.301611","volume":"114","author":"Y Boulaftali","year":"2014","unstructured":"Boulaftali Y, Hess PR, Kahn ML, Bergmeier W (2014) Platelet immunoreceptor tyrosine-based activation motif (ITAM) signaling and vascular integrity. Circ Res 114(7):1174\u20131184","journal-title":"Circ Res"},{"issue":"2","key":"2536_CR73","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1182\/blood-2002-12-3882","volume":"102","author":"B Nieswandt","year":"2003","unstructured":"Nieswandt B, Watson SP (2003) Platelet\u2013collagen interaction: is GPVI the central receptor? Blood 102(2):449\u2013461","journal-title":"Blood"},{"issue":"8","key":"2536_CR74","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1111\/j.1538-7836.2005.01429.x","volume":"3","author":"SP Watson","year":"2005","unstructured":"Watson SP, Auger JM, McCarty OJ, Pearce AC (2005) GPVI and integrin alphaIIb beta3 signaling in platelets. J Thromb Haemost 3(8):1752\u20131762","journal-title":"J Thromb Haemost"},{"issue":"7","key":"2536_CR75","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1161\/ATVBAHA.112.250464","volume":"32","author":"E Dunne","year":"2012","unstructured":"Dunne E, Spring CM, Reheman A, Jin W, Berndt MC, Newman DK, Newman PJ, Ni H, Kenny D (2012) Cadherin 6 has a functional role in platelet aggregation and thrombus formation. Arterioscler Thromb Vasc Biol 32(7):1724\u20131731","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"7","key":"2536_CR76","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1111\/j.1538-7836.2006.01943.x","volume":"4","author":"J Cho","year":"2006","unstructured":"Cho J, Mosher DF (2006) Role of fibronectin assembly in platelet thrombus formation. J Thromb Haemost 4(7):1461\u20131469","journal-title":"J Thromb Haemost"},{"issue":"2","key":"2536_CR77","first-page":"144","volume":"244","author":"MA Arneson","year":"1980","unstructured":"Arneson MA, Hammerschmidt DE, Furcht LT, King RA (1980) A new form of Ehlers-Danlos syndrome. Fibronectin corrects defective platelet function. JAMA 244(2):144\u2013147","journal-title":"Fibronectin corrects defective platelet function. JAMA"},{"issue":"1","key":"2536_CR78","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0006-291X(83)90391-1","volume":"116","author":"SA Santoro","year":"1983","unstructured":"Santoro SA (1983) Inhibition of platelet aggregation by fibronectin. Biochem Biophys Res Commun 116(1):135\u2013140","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"2536_CR79","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1182\/blood.V67.2.450.450","volume":"67","author":"DG Moon","year":"1986","unstructured":"Moon DG, Kaplan JE, Mazurkewicz JE (1986) The inhibitory effect of plasma fibronectin on collagen-induced platelet aggregation. Blood 67(2):450\u2013457","journal-title":"Blood"},{"issue":"8","key":"2536_CR80","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1182\/blood-2008-04-148361","volume":"113","author":"A Reheman","year":"2009","unstructured":"Reheman A, Yang H, Zhu G, Jin W, He F, Spring CM, Bai X, Gross PL, Freedman J, Ni H (2009) Plasma fibronectin depletion enhances platelet aggregation and thrombus formation in mice lacking fibrinogen and von Willebrand factor. Blood 113(8):1809\u20131817","journal-title":"Blood"},{"issue":"22","key":"2536_CR81","doi-asserted-by":"crossref","first-page":"11891","DOI":"10.1016\/S0021-9258(17)38962-7","volume":"260","author":"TK Gartner","year":"1985","unstructured":"Gartner TK, Bennett JS (1985) The tetrapeptide analogue of the cell attachment site of fibronectin inhibits platelet aggregation and fibrinogen binding to activated platelets. J Biol Chem 260(22):11891\u201311894","journal-title":"J Biol Chem"},{"issue":"3","key":"2536_CR82","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1172\/JCI9896","volume":"106","author":"H Ni","year":"2000","unstructured":"Ni H, Denis CV, Subbarao S, Degen JL, Sato TN, Hynes RO, Wagner DD (2000) Persistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogen. J Clin Invest 106(3):385\u2013392","journal-title":"J Clin Invest"},{"issue":"10","key":"2536_CR83","doi-asserted-by":"crossref","first-page":"4281","DOI":"10.1172\/JCI74630","volume":"124","author":"Y Wang","year":"2014","unstructured":"Wang Y, Reheman A, Spring CM, Kalantari J, Marshall AH, Wolberg AS, Gross PL, Weitz JI, Rand ML, Mosher DF, Freedman J, Ni H (2014) Plasma fibronectin supports hemostasis and regulates thrombosis. J Clin Invest 124(10):4281\u20134293","journal-title":"J Clin Invest"},{"issue":"10","key":"2536_CR84","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1182\/blood-2012-07-443325","volume":"121","author":"H Zhi","year":"2013","unstructured":"Zhi H, Rauova L, Hayes V, Gao C, Boylan B, Newman DK, McKenzie SE, Cooley BC, Poncz M, Newman PJ (2013) Cooperative integrin\/ITAM signaling in platelets enhances thrombus formation in vitro and in vivo. Blood 121(10):1858\u20131867","journal-title":"Blood"},{"key":"2536_CR85","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1111\/j.1538-7836.2005.01338.x","volume":"10","author":"DS Woulfe","year":"2005","unstructured":"Woulfe DS (2005) Platelet G protein-coupled receptors in hemostasis and thrombosis. J Thromb Haemost 10:2193\u20132200","journal-title":"J Thromb Haemost"},{"issue":"10","key":"2536_CR86","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1161\/CIRCULATIONAHA.105.574830","volume":"114","author":"AJ Leger","year":"2006","unstructured":"Leger AJ, Covic L, Kuliopulos A (2006) Protease-activated receptors in cardiovascular diseases. Circulation 114(10):1070\u20131077","journal-title":"Circulation"},{"issue":"6801","key":"2536_CR87","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/35025229","volume":"407","author":"SR Coughlin","year":"2000","unstructured":"Coughlin SR (2000) Thrombin signalling and protease-activated receptors. Nature 407(6801):258\u2013264","journal-title":"Nature"},{"issue":"4","key":"2536_CR88","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1161\/ATVBAHA.108.176388","volume":"29","author":"SS Smyth","year":"2009","unstructured":"Smyth SS, Woulfe DS, Weitz JI, Gachet C, Conley PB, Goodman SG, Roe MT, Kuliopulos A, Moliterno DJ, French PA, Steinhubl SR, Becker RC (2009) G-protein-coupled receptors as signaling targets for antiplatelet therapy. Arterioscler Thromb Vasc Biol 29(4):449\u2013457","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"2536_CR89","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1161\/CIRCRESAHA.111.300271","volume":"112","author":"DJ Fitzgerald","year":"2013","unstructured":"Fitzgerald DJ, Fitzgerald GA (2013) Historical lessons in translational medicine: cyclooxygenase inhibition and P2Y12 antagonism. Circ Res 112(1):174\u2013194","journal-title":"Circ Res"},{"issue":"3","key":"2536_CR90","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1055\/s-0037-1614344","volume":"82","author":"UR Schwarz","year":"1999","unstructured":"Schwarz UR, Geiger J, Walter U, Eigenthaler M (1999) Flow cytometry analysis of intracellular VASP phosphorylation for the assessment of activating and inhibitory signal transduction pathways in human platelets\u2014definition and detection of ticlopidine\/clopidogrel effects. Thromb Haemost 82(3):1145\u20131152","journal-title":"Thromb Haemost"},{"issue":"4","key":"2536_CR91","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1172\/JCI118518","volume":"97","author":"T Hirata","year":"1996","unstructured":"Hirata T, Ushikubi F, Kakizuka A, Okuma M, Narumiya S (1996) Two thromboxane A2 receptor isoforms in human platelets. Opposite coupling to adenylyl cyclase with different sensitivity to Arg60 to Leu mutation. J Clin Invest 97(4):949\u2013956","journal-title":"J Clin Invest"},{"issue":"1","key":"2536_CR92","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1476-5381.2009.00121.x","volume":"158","author":"S Siehler","year":"2009","unstructured":"Siehler S (2009) Regulation of RhoGEF proteins by G12\/13-coupled receptors. Br J Pharmacol 158(1):41\u201349","journal-title":"Br J Pharmacol"},{"issue":"41","key":"2536_CR93","doi-asserted-by":"crossref","first-page":"29108","DOI":"10.1074\/jbc.274.41.29108","volume":"274","author":"BZ Paul","year":"1999","unstructured":"Paul BZ, Jin J, Kunapuli SP (1999) Molecular mechanism of thromboxane A(2)-induced platelet aggregation. Essential role for p2t(ac) and alpha(2a) receptors. J Biol Chem 274(41):29108\u201329114","journal-title":"J Biol Chem"},{"issue":"24","key":"2536_CR94","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1056\/NEJMra071014","volume":"357","author":"G Dav\u00ec","year":"2007","unstructured":"Dav\u00ec G, Patrono C (2007) Platelet activation and atherothrombosis. N Engl J Med 357(24):2482\u20132494","journal-title":"N Engl J Med"},{"issue":"6","key":"2536_CR95","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1080\/10408363.2016.1200008","volume":"53","author":"XR Xu","year":"2016","unstructured":"Xu XR, Zhang D, Oswald BE, Carrim N, Wang X, Hou Y, Zhang Q, Lavalle C, McKeown T, Marshall AH, Ni H (2016) Platelets are versatile cells: New discoveries in hemostasis, thrombosis, immune responses, tumor metastasis and beyond. Crit Rev Clin Lab Sci 53(6):409\u2013430","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"5","key":"2536_CR96","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ccr.2011.09.009","volume":"20","author":"M Labelle","year":"2011","unstructured":"Labelle M, Begum S, Hynes RO (2011) Direct signaling between platelets and cancer cells induces an epithelial\u2013mesenchymal-like transition and promotes metastasis. Cancer Cell 20(5):576\u2013590","journal-title":"Cancer Cell"},{"issue":"1","key":"2536_CR97","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1124\/mol.113.084988","volume":"84","author":"M Dovizio","year":"2013","unstructured":"Dovizio M, Maier TJ, Alberti S, Di Francesco L, Marcantoni E, M\u00fcnch G, John CM, Suess B, Sgambato A, Steinhilber D, Patrignani P (2013) Pharmacological inhibition of platelet\u2013tumor cell cross-talk prevents platelet-induced overexpression of cyclooxygenase-2 in HT29 human colon carcinoma cells. Mol Pharmacol 84(1):25\u201340","journal-title":"Mol Pharmacol"},{"issue":"22","key":"2536_CR98","doi-asserted-by":"crossref","first-page":"32462","DOI":"10.18632\/oncotarget.8655","volume":"7","author":"P Guillem-Llobat","year":"2016","unstructured":"Guillem-Llobat P, Dovizio M, Bruno A, Ricciotti E, Cufino V, Sacco A, Grande R, Alberti S, Arena V, Cirillo M, Patrono C, FitzGerald GA, Steinhilber D, Sgambato A, Patrignani P (2016) Aspirin prevents colorectal cancer metastasis in mice by splitting the crosstalk between platelets and tumor cells. Oncotarget 7(22):32462\u201332477","journal-title":"Oncotarget"},{"issue":"6","key":"2536_CR99","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/onc.2009.421","volume":"29","author":"D Wang","year":"2010","unstructured":"Wang D, Dubois RN (2010) The role of COX-2 in intestinal inflammation and colorectal cancer. Oncogene 29(6):781\u2013788","journal-title":"Oncogene"},{"issue":"17","key":"2536_CR100","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1161\/CIRCULATIONAHA.110.980623","volume":"123","author":"M Ungerer","year":"2011","unstructured":"Ungerer M, Rosport K, B\u00fcltmann A, Piechatzek R, Uhland K, Schlieper P, Gawaz M, M\u00fcnch G (2011) Novel antiplatelet drug revacept (Dimeric Glycoprotein VI-Fc) specifically and efficiently inhibited collagen-induced platelet aggregation without affecting general hemostasis in humans. Circulation 123(17):1891\u20131899","journal-title":"Circulation"},{"key":"2536_CR101","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1182\/blood-2013-02-485011","volume":"123","author":"EM Battinelli","year":"2014","unstructured":"Battinelli EM, Markens BA, Kulenthirarajan RA, Machlus KR, Flaumenhaft R, Italiano JE Jr (2014) Anticoagulation inhibits tumor cell-mediated release of platelet angiogenic proteins and diminishes platelet angiogenic response. Blood 123:101\u2013112","journal-title":"Blood"},{"issue":"5","key":"2536_CR102","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ccr.2006.10.002","volume":"10","author":"ML Nierodzik","year":"2006","unstructured":"Nierodzik ML, Karpatkin S (2006) Thrombin induces tumor growth, metastasis, and angiogenesis: evidence for a thrombin-regulated dormant tumor phenotype. Cancer Cell 10(5):355\u2013362","journal-title":"Cancer Cell"},{"issue":"1\u20132","key":"2536_CR103","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000046586","volume":"106","author":"AJ Gale","year":"2001","unstructured":"Gale AJ, Gordon SG (2001) Update on tumor cell procoagulant factors. Acta Haematol 106(1\u20132):25\u201332","journal-title":"Acta Haematol"},{"issue":"2","key":"2536_CR104","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1182\/blood-2013-03-492447","volume":"123","author":"A Mitrugno","year":"2014","unstructured":"Mitrugno A, Williams D, Kerrigan SW, Moran N (2014) A novel and essential role for Fc\u03b3RIIa in cancer cell-induced platelet activation. Blood 123(2):249\u2013260","journal-title":"Blood"},{"issue":"19","key":"2536_CR105","first-page":"4425","volume":"55","author":"G Mannori","year":"1995","unstructured":"Mannori G, Crottet P, Cecconi O, Hanasaki K, Aruffo A, Nelson RM, Varki A, Bevilacqua MP (1995) Differential colon cancer cell adhesion to E-, P-, and L-selectin: role of mucin-type glycoproteins. Cancer Res 55(19):4425\u20134431","journal-title":"Cancer Res"},{"issue":"2","key":"2536_CR106","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1182\/blood.V74.2.658.658","volume":"74","author":"H Boukerche","year":"1989","unstructured":"Boukerche H, Berthier-Vergnes O, Tabone E, Dor\u00e9 JF, Leung LL, McGregor JL (1989) Platelet\u2013melanoma cell interaction is mediated by the glycoprotein IIb\u2013IIIa complex. Blood 74(2):658\u2013663","journal-title":"Blood"},{"issue":"1","key":"2536_CR107","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1172\/JCI114976","volume":"87","author":"ML Nierodzik","year":"1991","unstructured":"Nierodzik ML, Plotkin A, Kajumo F, Karpatkin S (1991) Thrombin stimulates tumor-platelet adhesion in vitro and metastasis in vivo. J Clin Invest 87(1):229\u2013236","journal-title":"J Clin Invest"},{"issue":"4","key":"2536_CR108","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1172\/JCI113411","volume":"81","author":"S Karpatkin","year":"1988","unstructured":"Karpatkin S, Pearlstein E, Ambrogio C, Coller BS (1988) Role of adhesive proteins in platelet tumor interaction in vitro and metastasis formation in vivo. J Clin Invest 81(4):1012\u20131019","journal-title":"J Clin Invest"},{"issue":"14","key":"2536_CR109","doi-asserted-by":"crossref","first-page":"e88245","DOI":"10.1172\/jci.insight.88245","volume":"1","author":"E Mammadova-Bach","year":"2016","unstructured":"Mammadova-Bach E, Zigrino P, Brucker C, Bourdon C, Freund M, De Arcangelis A, Abrams SI, Orend G, Gachet C, Mangin PH (2016) Platelet integrin \u03b16\u03b21 controls lung metastasis through direct binding to cancer cell-derived ADAM9. JCI Insight 1(14):e88245","journal-title":"JCI Insight"},{"key":"2536_CR110","first-page":"282","volume":"3","author":"JM Gerrard","year":"1001","unstructured":"Gerrard JM (1001) Robinson P (1989) Identification of the molecular species of lysophosphatidic acid produced when platelets are stimulated by thrombin. Biochim Biophys Acta 3:282\u2013285","journal-title":"Biochim Biophys Acta"},{"issue":"25","key":"2536_CR111","doi-asserted-by":"crossref","first-page":"17304","DOI":"10.1074\/jbc.M109.003194","volume":"284","author":"JR Williams","year":"2009","unstructured":"Williams JR, Khandoga AL, Goyal P, Fells JI, Perygin DH, Siess W, Parrill AL, Tigyi G, Fujiwara Y (2009) Unique ligand selectivity of the GPR92\/LPA5 lysophosphatidate receptor indicates role in human platelet activation. J Biol Chem 284(25):17304\u201317319","journal-title":"J Biol Chem"},{"issue":"8","key":"2536_CR112","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/nrc1143","volume":"3","author":"GB Mills","year":"2003","unstructured":"Mills GB, Moolenaar WH (2003) The emerging role of lysophosphatidic acid in cancer. Nat Rev Cancer 3(8):582\u2013591","journal-title":"Nat Rev Cancer"},{"issue":"12","key":"2536_CR113","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1172\/JCI200422123","volume":"114","author":"A Boucharaba","year":"2004","unstructured":"Boucharaba A, Serre CM, Gr\u00e8s S, Saulnier-Blache JS, Bordet JC, Guglielmi J, Cl\u00e9zardin P, Peyruchaud O (2004) Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer. J Clin Invest 114(12):1714\u20131725","journal-title":"J Clin Invest"},{"issue":"25","key":"2536_CR114","doi-asserted-by":"crossref","first-page":"9643","DOI":"10.1073\/pnas.0600979103","volume":"103","author":"A Boucharaba","year":"2006","unstructured":"Boucharaba A, Serre CM, Guglielmi J, Bordet JC, Cl\u00e9zardin P, Peyruchaud O (2006) The type 1 lysophosphatidic acid receptor is a target for therapy in bone metastases. Proc Natl Acad Sci USA 103(25):9643\u20139648","journal-title":"Proc Natl Acad Sci USA"},{"issue":"20","key":"2536_CR115","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1182\/blood-2014-04-568683","volume":"124","author":"R Leblanc","year":"2014","unstructured":"Leblanc R, Lee SC, David M, Bordet JC, Norman DD, Patil R, Miller D, Sahay D, Ribeiro J, Cl\u00e9zardin P, Tigyi GJ, Peyruchaud O (2014) Interaction of platelet-derived autotaxin with tumor integrin \u03b1V\u03b23 controls metastasis of breast cancer cells to bone. Blood 124(20):3141\u20133150","journal-title":"Blood"},{"issue":"36","key":"2536_CR116","doi-asserted-by":"crossref","first-page":"22143","DOI":"10.1074\/jbc.M115.641092","volume":"290","author":"RJ Burkhalter","year":"2015","unstructured":"Burkhalter RJ, Westfall SD, Liu Y, Stack MS (2015) Lysophosphatidic acid initiatesepithelial to mesenchymal transition and induces \u03b2-catenin-mediated transcription in epithelial ovarian carcinoma. J Biol Chem 290(36):22143\u201322154","journal-title":"J Biol Chem"},{"issue":"25","key":"2536_CR117","doi-asserted-by":"crossref","first-page":"37664","DOI":"10.18632\/oncotarget.9224","volume":"7","author":"JH Ha","year":"2016","unstructured":"Ha JH, Ward JD, Radhakrishnan R, Jayaraman M, Song YS, Dhanasekaran DN (2016) Lysophosphatidic acid stimulates epithelial to mesenchymal transition marker Slug\/Snail2 in ovarian cancer cells via G\u03b1i2, Src, and HIF1\u03b1 signaling nexus. Oncotarget 7(25):37664\u201337679","journal-title":"Oncotarget"},{"issue":"9759","key":"2536_CR118","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(10)62110-1","volume":"377","author":"PM Rothwell","year":"2011","unstructured":"Rothwell PM, Fowkes FG, Belch JF, Ogawa H, Warlow CP, Meade TW (2011) Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials. Lancet 377(9759):31\u201341","journal-title":"Lancet"},{"issue":"9826","key":"2536_CR119","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/S0140-6736(11)61720-0","volume":"379","author":"PM Rothwell","year":"2012","unstructured":"Rothwell PM, Price JF, Fowkes FG, Zanchetti A, Roncaglioni MC, Tognoni G, Lee R, Belch JF, Wilson M, Mehta Z, Meade TW (2012) Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials. Lancet 379(9826):1602\u20131612","journal-title":"Lancet"},{"issue":"3","key":"2536_CR120","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1124\/pr.56.3.3","volume":"56","author":"DL Simmons","year":"2004","unstructured":"Simmons DL, Botting RM, Hla T (2004) Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Pharmacol Rev 56(3):387\u2013437","journal-title":"Pharmacol Rev"},{"issue":"8","key":"2536_CR121","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/nsb0895-637","volume":"2","author":"PJ Loll","year":"1995","unstructured":"Loll PJ, Picot D, Garavito RM (1995) The structural basis of aspirin activity inferred from the crystal structure of inactivated prostaglandin H2 synthase. Nat Struct Biol 2(8):637\u2013643","journal-title":"Nat Struct Biol"},{"issue":"18","key":"2536_CR122","doi-asserted-by":"crossref","first-page":"13207","DOI":"10.1016\/S0021-9258(17)36820-5","volume":"269","author":"M Lecomte","year":"1994","unstructured":"Lecomte M, Laneuville O, Ji C, DeWitt DL, Smith WL (1994) Acetylation of human prostaglandin endoperoxide synthase-2 (cyclooxygenase-2) by aspirin. J Biol Chem 269(18):13207\u201313215","journal-title":"J Biol Chem"},{"issue":"6","key":"2536_CR123","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1172\/JCI110576","volume":"69","author":"P Patrignani","year":"1982","unstructured":"Patrignani P, Filabozzi P, Patrono C (1982) Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects. J Clin Invest 69(6):1366\u20131372","journal-title":"J Clin Invest"},{"issue":"8","key":"2536_CR124","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1111\/jth.12637","volume":"12","author":"P Patrignani","year":"2014","unstructured":"Patrignani P, Tacconelli S, Piazuelo E, Di Francesco L, Dovizio M, Sostres C, Marcantoni E, Guillem-Llobat P, Del Boccio P, Zucchelli M, Patrono C, Lanas A (2014) Reappraisal of the clinical pharmacology of low-dose aspirin by comparing novel direct and traditional indirect biomarkers of drug action. J Thromb Haemost 12(8):1320\u20131330","journal-title":"J Thromb Haemost"},{"issue":"1","key":"2536_CR125","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1172\/JCI200113418","volume":"108","author":"C Patrono","year":"2001","unstructured":"Patrono C, Patrignani P, Garc\u00eda Rodr\u00edguez LA (2001) Cyclooxygenase-selective inhibition of prostanoid formation: transducing biochemical selectivity into clinical read-outs. J Clin Invest 108(1):7\u201313","journal-title":"J Clin Invest"},{"issue":"35","key":"2536_CR126","doi-asserted-by":"crossref","first-page":"5116","DOI":"10.2174\/1381612821666150915110706","volume":"21","author":"L Francesco Di","year":"2015","unstructured":"Di Francesco L, L\u00f3pez Contreras LA, Sacco A, Patrignani P (2015) New insights into the mechanism of action of aspirin in the prevention of colorectal neoplasia. Curr Pharm Des 21(35):5116\u20135126","journal-title":"Curr Pharm Des"},{"key":"2536_CR127","doi-asserted-by":"crossref","unstructured":"Patrignani P, Sacco A, Sostres C, Bruno A, Dovizio M, Piazuelo E, Di Francesco L, Contursi A, Zucchelli M, Schiavone S, Tacconelli S, Patrono C, Lanas A (2017) Low-dose aspirin acetylates cyclooxygenase-1 in human colorectal mucosa: implications for the chemoprevention of colorectal cancer. Clin Pharmacol Ther (Epub ahead of print)","DOI":"10.1002\/cpt.639"},{"issue":"18","key":"2536_CR128","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1101\/gad.351605","volume":"19","author":"I Ruvinsky","year":"2005","unstructured":"Ruvinsky I, Sharon N, Lerer T, Cohen H, Stolovich-Rain M, Nir T, Dor Y, Zisman P, Meyuhas O (2005) Ribosomal protein S6 phosphorylation is a determinant of cell size and glucose homeostasis. Genes Dev 19(18):2199\u20132211","journal-title":"Genes Dev"},{"issue":"1","key":"2536_CR129","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1161\/CIRCULATIONAHA.109.853069","volume":"121","author":"M Cattaneo","year":"2010","unstructured":"Cattaneo M (2010) New P2Y(12) inhibitors. Circulation 121(1):171\u2013179","journal-title":"Circulation"},{"issue":"11","key":"2536_CR130","doi-asserted-by":"crossref","first-page":"e80780","DOI":"10.1371\/journal.pone.0080780","volume":"8","author":"Y Wang","year":"2013","unstructured":"Wang Y, Sun Y, Li D, Zhang L, Wang K, Zuo Y, Gartner TK, Liu J (2013) Platelet P2Y12 is involved in murine pulmonary metastasis. PLoS One 8(11):e80780","journal-title":"PLoS One"},{"issue":"32","key":"2536_CR131","doi-asserted-by":"crossref","first-page":"E2165","DOI":"10.1073\/pnas.1209182109","volume":"109","author":"G Sitia","year":"2012","unstructured":"Sitia G, Aiolfi R, Di Lucia P, Mainetti M, Fiocchi A, Mingozzi F, Esposito A, Ruggeri ZM, Chisari FV, Iannacone M, Guidotti LG (2012) Antiplatelet therapy prevents hepatocellular carcinoma and improves survival in a mouse model of chronic hepatitis B. Proc Natl Acad Sci USA 109(32):E2165\u2013E2172","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"2536_CR132","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1055\/s-0038-1642691","volume":"74","author":"ML Nierodzik","year":"1995","unstructured":"Nierodzik ML, Klepfish A, Karpatkin S (1995) Role of platelets, thrombin, integrin IIb-IIIa, fibronectin and von Willebrand factor on tumor adhesion in vitro and metastasis in vivo. Thromb Haemost 74(1):282\u2013290","journal-title":"Thromb Haemost"},{"issue":"3","key":"2536_CR133","first-page":"549","volume":"90","author":"A Amirkhosravi","year":"2003","unstructured":"Amirkhosravi A, Mousa SA, Amaya M, Blaydes S, Desai H, Meyer T, Francis JL (2003) Inhibition of tumor cell-induced platelet aggregation and lung metastasis by the oral GpIIb\/IIIa antagonist XV454. Thromb Haemost 90(3):549\u2013554","journal-title":"Thromb Haemost"},{"issue":"3","key":"2536_CR134","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1182\/blood-2007-09-113837","volume":"111","author":"JE Italiano Jr","year":"2008","unstructured":"Italiano JE Jr, Richardson JL, Patel-Hett S, Battinelli E, Zaslavsky A, Short S, Ryeom S, Folkman J, Klement GL (2008) Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released. Blood 111(3):1227\u20131233","journal-title":"Blood"},{"key":"2536_CR135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vph.2017.01.003","volume":"89","author":"M Dovizio","year":"2017","unstructured":"Dovizio M, Sacco A, Patrignani P (2017) Curbing tumorigenesis and malignant progression through the pharmacological control of the wound healing process. Vasc Pharmacol 89:1\u201311","journal-title":"Vasc Pharmacol"},{"issue":"2","key":"2536_CR136","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1182\/blood-2004-02-0434","volume":"104","author":"E Camerer","year":"2004","unstructured":"Camerer E, Qazi AA, Duong DN, Cornelissen I, Advincula R, Coughlin SR (2004) Platelets, protease-activated receptors, and fibrinogen in hematogenous metastasis. Blood 104(2):397\u2013401","journal-title":"Blood"},{"issue":"10","key":"2536_CR137","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1111\/j.1538-7836.2009.03559.x","volume":"7","author":"S Jain","year":"2009","unstructured":"Jain S, Russell S, Ware J (2009) Platelet glycoprotein VI facilitates experimental lung metastasis in syngenic mouse models. J Thromb Haemost 7(10):1713\u20131717","journal-title":"J Thromb Haemost"},{"issue":"1","key":"2536_CR138","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s12307-008-0003-6","volume":"1","author":"P Nangia-Makker","year":"2008","unstructured":"Nangia-Makker P, Balan V, Raz A (2008) Regulation of tumor progression by extracellular galectin-3. Cancer Microenviron 1(1):43\u201351","journal-title":"Cancer Microenviron"},{"issue":"2","key":"2536_CR139","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s11239-011-0577-6","volume":"32","author":"LJ Schober","year":"2011","unstructured":"Schober LJ, Khandoga AL, Dwivedi S, Penz SM, Maruyama T, Brandl R, Siess W (2011) The role of PGE(2) in human atherosclerotic plaque on platelet EP(3) and EP(4) receptor activation and platelet function in whole blood. J Thromb Thrombolysis 32(2):158\u2013166","journal-title":"J Thromb Thrombolysis"},{"key":"2536_CR140","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1021\/cb8002094","volume":"4","author":"J Singh","year":"2009","unstructured":"Singh J, Zeller W, Zhou N, Hategen G, Mishra R, Polozov A, Yu P, Onua E, Zhang J, Zembower D, Kiselyov A, Ram\u00edrez JL, Sigthorsson G (2009) Antagonists of the EP3 receptor for prostaglandin E2 are novel antiplatelet agents that do not prolong bleeding. ACS Chem Biol 4:115\u2013126","journal-title":"ACS Chem Biol"},{"issue":"5","key":"2536_CR141","doi-asserted-by":"crossref","first-page":"392","DOI":"10.3109\/09537104.2012.704648","volume":"24","author":"SC Fox","year":"2013","unstructured":"Fox SC, May JA, Johnson A, Hermann D, Strieter D, Hartman D, Heptinstall S (2013) Effects on platelet function of an EP3 receptor antagonist used alone and in combination with a P2Y12 antagonist both in vitro and ex vivo in human volunteers. Platelets 24(5):392\u2013400","journal-title":"Platelets"},{"issue":"4","key":"2536_CR142","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/nri2956","volume":"11","author":"JW Semple","year":"2011","unstructured":"Semple JW, Italiano JE Jr, Freedman J (2011) Platelets and the immune continuum. Nat Rev Immunol 11(4):264\u2013274","journal-title":"Nat Rev Immunol"},{"key":"2536_CR143","first-page":"384685","volume":"2012","author":"C Li","year":"2012","unstructured":"Li C, Li J, Li Y, Lang S, Yougbare I, Zhu G, Chen P, Ni H (2012) Crosstalk between platelets and the immune system: old systems with new discoveries. Adv Hematol 2012:384685","journal-title":"Adv Hematol"},{"issue":"6","key":"2536_CR144","first-page":"1295","volume":"59","author":"B Nieswandt","year":"1999","unstructured":"Nieswandt B, Hafner M, Echtenacher B, Mannel DN (1999) Lysis of tumor cells by natural killer cells in mice is impeded by platelets. Cancer Res 59(6):1295\u20131300","journal-title":"Cancer Res"},{"issue":"6","key":"2536_CR145","first-page":"83","volume":"2","author":"F Cognasse","year":"2015","unstructured":"Cognasse F, Nguyen KA, Damien P, McNicol A, Pozzetto B, Hamzeh-Cognasse H, Garraud O (2015) The inflammatory role of platelets via their TLRs and Siglec receptors. Front Immunol 2(6):83","journal-title":"Front Immunol"},{"issue":"6","key":"2536_CR146","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nrmicro3269","volume":"12","author":"MR Yeaman","year":"2014","unstructured":"Yeaman MR (2014) Platelets: at the nexus of antimicrobial defence. Nat Rev Microbiol 12(6):426\u2013437","journal-title":"Nat Rev Microbiol"},{"issue":"9","key":"2536_CR147","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1161\/CIRCRESAHA.111.256370","volume":"110","author":"HF Langer","year":"2012","unstructured":"Langer HF, Choi EY, Zhou H, Schleicher R, Chung KJ, Tang Z, G\u00f6bel K, Bdeir K, Chatzigeorgiou A, Wong C, Bhatia S, Kruhlak MJ, Rose JW, Burns JB, Hill KE, Qu H, Zhang Y, Lehrmann E, Becker KG, Wang Y, Simon DI, Nieswandt B, Lambris JD, Li X, Meuth SG, Kubes P, Chavakis T (2012) Platelets contribute to the pathogenesis of experimental autoimmune encephalomyelitis. Circ Res 110(9):1202\u20131210","journal-title":"Circ Res"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00018-017-2536-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-017-2536-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-017-2536-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T05:54:01Z","timestamp":1750226041000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00018-017-2536-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,9]]},"references-count":147,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["2536"],"URL":"https:\/\/doi.org\/10.1007\/s00018-017-2536-7","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,9]]}}}